PROTEST

Adc Therapeutics Announces Japan Filing for Zynlonta in Relapsed or Refractory Lymphoma

PROTEST signal, reported in JA, from rttnews.com, with neutral sentiment. Locations: Japan.

Sourcesrttnews.com +3
Event Time29 Oct 2026, 6:45 PM GMT
CountryJA
SentimentNeutral / Tone 2.78

What This Signal Means

This page turns one GDELT event record into a readable WorldEchoNews signal. The signal is categorized as PROTEST for JA, with neutral sentiment and a tone score of 2.78. 4 distinct reporting sources linked to this event.

Tone Reading

The tone score is used as a quick language-intensity indicator. Scores below -5 are treated as negative, scores above 5 are treated as positive, and values between -5 and 5 are treated as neutral. This signal has a moderate neutral reading.

Reporting Sources

These source names were attached to matching GDELT mentions for this event.

banglamirrornews.com canadianinquirer.net openthemagazine.com rttnews.com
People: Tanabe Pharma
Organizations: Nippon Shinyaku Co Ltd, Japan Ministry Of Health, European Commission, Tanabe Pharma Corporation
Locations: Japan
View original source

Activity in JA (last 24 hours)

98signals recorded
-1.35average tone
7strongly negative

Counted across every source WorldEchoNews processed in the window, not just this story.

Other signals from JA